Bengt Lindahl (Former)
1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Adjuvant tamoxifen in breast cancer patients affects the endometrium by time, an effect remaining years after end of treatment and results in an increased frequency of endometrial carcinoma.
(
- Contribution to journal › Article
- 2007
-
Mark
Prospective malignancy grading of invasive squamous carcinoma of the uterine cervix. Prognostic significance in a long-term follow-up.
(
- Contribution to journal › Article
- 2004
-
Mark
A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I-II endometrial cancer
(
- Contribution to journal › Article
- 2002
-
Mark
Similarity of uterine mucosa changes in patients treated by Raloxifen and Tamoxifen
(
- Contribution to journal › Article
- 1991
-
Mark
DNA ploidy assessment of breast milk (colostrum) in primiparous women of different ages
(
- Contribution to journal › Article
- 1987
-
Mark
Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age
(
- Contribution to journal › Article
- 1982
-
Mark
Correlation between estradiol-17 beta and progesterone cytosol receptor concentration, histologic differentiation and 3H-thymidine incorporation in endometrial carcinoma
(
- Contribution to journal › Article